M.G. Finn


M.G.

 

Finn

Chair and Professor
Primary School/Department: 
Georgia Tech School of Chemistry and Biochemistry
Title 2: 
James A. Carlos Family Chair for Pediatric Technology

Phone: 
404-385-0906
Office Location: 
MoSE 2201B
University: 
Georgia Institute of Technology

Research Affiliations:

Research Center Affiliations: 
Center for Medical Robotics
Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M)
Regenerative Engineering and Medicine (REM)
Immunoengineering
Center for ImmunoEngineering
Center for Drug Design Development & Delivery
Center for Chemical Evolution

Research Areas:

Research Areas: 
Biomaterials
Drug Design, Development and Delivery
Molecular Evolution

Research Interests:

We develop chemical and biological tools for research in a wide range of fields. Some of them are briefly described below; please see our group web page for more details.

Chemistry, biology, immunology, and evolution with viruses. The sizes and properties of virus particles put them at the interface between the worlds of chemistry and biology. We use techniques from both fields to tailor these particles for applications to cell targeting, diagnostics, vaccine development, catalysis, and materials self-assembly. This work involves combinations of small-molecule and polymer synthesis, bioconjugation, molecular biology, protein design, protein evolution, bioanalytical chemistry, enzymology, physiology, and immunology. It is an exciting training ground for modern molecular scientists and engineers.

Development of reactions for organic synthesis, chemical biology, and materials science.  Molecular function is what matters most to our scientific lives, and good chemical reactions provide the means to achieve such function. We continue our efforts to develop and optimize reactions that meet the click chemistry standard for power and generality. Our current focus is on highly reliable reversible reactions, which open up new possibilities for polymer synthesis and modification, as well as for the controlled delivery of therapeutic and diagnostic agents to biological targets.

Traditional and combinatorial synthesis of biologically active compounds.  We have a longstanding interest in the development of biologically active small molecules. We work closely with industrial and academic collaborators on such targets as antiviral agents, compounds to combat tobacco addiction, and treatments for inflammatory disease.